| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) | 
|---|
| 10/09/2014 | US20140301992 Compositions, methods and uses for treating solid tumors using lcmv-gp-vsv pseudotype vectors | 
| 10/09/2014 | US20140301974 Extended recombinant polypeptides and compositions comprising same | 
| 10/08/2014 | EP2787349A1 Method for detecting proteinopathy-specific antibodies in a biological sample | 
| 10/08/2014 | EP2787004A1 A method for predicting a "mantled" phenotype in oil palm plants and minimizing the percentage of oil palm plants with a "mantled" phenotype in a culture, and polynucleotide to be used therein | 
| 10/08/2014 | EP2787003A1 Antimicrobial peptide produced by marine sponge-derived Bacillus subtilis | 
| 10/08/2014 | EP2785843A1 Novel enhanced selectin antagonists | 
| 10/08/2014 | EP2785841A2 Anti-fh aptamers, method for producing same, and uses thereof | 
| 10/08/2014 | EP2785838A2 Targeted lysosomal enzyme compounds | 
| 10/08/2014 | EP2785837A2 Targeted enzyme compounds and uses thereof | 
| 10/08/2014 | EP2785744A1 Protein inhibitors to complement and vegf pathways and methods of use thereof | 
| 10/08/2014 | EP2785735A1 Clonable tag for correlative light and electron microscopy labeling | 
| 10/08/2014 | EP2785734A1 Gm1 ganglioside to annexin v microparticle polypeptide ratio for biological monitoring | 
| 10/08/2014 | EP2785733A1 Inotropic compounds | 
| 10/08/2014 | EP2785732A1 Polypeptides having beta-xylosidase activity and polynucleotides encoding same | 
| 10/08/2014 | EP2785731A1 Vectors and host cells comprising a modified sv40 promoter for protein expression | 
| 10/08/2014 | EP2785372A1 Influenza virus vaccines and uses thereof | 
| 10/08/2014 | EP2785364A1 Use of p3 of bacteriophage as amyloid binding agents | 
| 10/08/2014 | EP2785362A2 Anticancer fusion protein | 
| 10/08/2014 | EP2785197A1 Method for producing a protein hydrolysate | 
| 10/07/2014 | US8853497 Soybean variety A1026219 | 
| 10/07/2014 | US8853494 Stress tolerant transgenic crop plants | 
| 10/07/2014 | US8853492 Plants having improved growth characteristics and a method for making the same | 
| 10/07/2014 | US8853490 Antifungal proteins and methods of use | 
| 10/07/2014 | US8853381 Signal peptide for producing a polypeptide | 
| 10/07/2014 | US8853380 Modified SAK gene for the production of recombinant proteins | 
| 10/07/2014 | US8853379 Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection | 
| 10/07/2014 | US8853378 Polynucleotides that home to atherosclerotic plaque | 
| 10/07/2014 | US8853370 Plant-produced glycoprotein comprising human-type sugar chain | 
| 10/07/2014 | US8853364 Prostate stem cell antigen (PSCA) variants and subsequences thereof | 
| 10/07/2014 | US8853363 Substance binding human IgG Fc receptor IIb (FcγRIIb) | 
| 10/07/2014 | US8853361 Preparation, for use, in particular, for tissue augmentation and healing | 
| 10/07/2014 | US8853360 Engineered botulinum neurotoxin C1 with selective substrate specificity | 
| 10/07/2014 | US8853358 Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage | 
| 10/07/2014 | US8853354 Polyion complex comprising hydrophobized polyamino acid and use of the same | 
| 10/07/2014 | US8853325 Water-soluble polymer alkanals | 
| 10/07/2014 | US8853166 Neurotrophic factor MANF and uses thereof | 
| 10/07/2014 | US8853165 Peptide having the ability to regenerate bone tissue and for binding to apatite | 
| 10/07/2014 | US8853164 Oligopeptide improving differentiation of osteoblasts | 
| 10/07/2014 | US8853163 Methods for increasing vascular density and maintaining viability of microvascular endothelial cells using trk receptor ligands | 
| 10/07/2014 | US8853162 Interpenetrating polymer network comprising fibrin | 
| 10/07/2014 | US8853161 Glycopegylation methods and proteins/peptides produced by the methods | 
| 10/07/2014 | US8853160 GLP-1, exendin-4, peptide analogs and uses thereof | 
| 10/07/2014 | US8853159 GLP-1 Fusion Peptides | 
| 10/07/2014 | US8853156 Treatment for diabetes in patients inappropriate for metformin therapy | 
| 10/07/2014 | US8853155 Insulin derivatives containing additional disulfide bonds | 
| 10/07/2014 | US8853154 Fibronectin based scaffold domain proteins that bind to myostatin | 
| 10/07/2014 | US8853150 Chimeric IL-1 receptor type I antagonists | 
| 10/07/2014 | US8853145 BLID; a novel protein domain for interaction with the Bcl-2 family of proteins | 
| 10/07/2014 | US8853131 Modified Stefin A scaffold proteins | 
| 10/07/2014 | US8852953 Immunodetection and quantification of pyrazolopyrimidine sedatives | 
| 10/07/2014 | US8852939 Use of Vgll3 activity modulator for the modulation of adipogenesis | 
| 10/07/2014 | US8852927 Microorganisms for imaging and/or treatment of tumors | 
| 10/07/2014 | US8852917 Thuricin CD, an antimicrobial for specifically targeting Clostridium difficile | 
| 10/07/2014 | US8852914 Flavivirus vaccines | 
| 10/07/2014 | US8852913 Variants of beta-glucosidases | 
| 10/07/2014 | US8852909 Ketoreductase polypeptides for the reduction of acetophenones | 
| 10/07/2014 | US8852903 Co-metabolism of fructose and glucose in microbial production strains | 
| 10/07/2014 | US8852899 Methods of making nylon intermediates from glycerol | 
| 10/07/2014 | US8852890 Production of bacterial strains | 
| 10/07/2014 | US8852882 Biosensors and their use | 
| 10/07/2014 | US8852866 Method for producing and identifying soluble protein domains | 
| 10/07/2014 | US8852860 Sperm-specific cation channel, CatSper1 and uses therefor | 
| 10/07/2014 | US8852666 Protective hydrocolloid for active ingredients | 
| 10/07/2014 | US8852612 Universal carrier for targeting molecules to Gb3 receptor expressing cells | 
| 10/07/2014 | US8852611 Compositions and methods for vaccinating against HSV-2 | 
| 10/07/2014 | US8852610 Compositions and methods for vaccinating against HSV-2 | 
| 10/07/2014 | US8852609 Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same | 
| 10/07/2014 | US8852608 Antibodies against and methods for producing vaccines for respiratory syncytial virus | 
| 10/07/2014 | US8852606 Capsular polysaccharide solubilisation and combination vaccines | 
| 10/07/2014 | US8852604 Multiepitope vaccine for Her2/neu-associated cancers | 
| 10/07/2014 | US8852603 Inhibition of secretion from non-neuronal cells | 
| 10/07/2014 | US8852602 Immunological herpes simplex virus antigens and methods for use thereof | 
| 10/07/2014 | US8852600 Codon-optimized DNA molecules encoding the receptor binding domains of Clostridium difficile toxins A and B, and methods of use thereof | 
| 10/07/2014 | US8852577 Recombinant proteins of Parapoxvirus ovis and pharmaceutical compositions therefrom | 
| 10/07/2014 | US8852576 Modified sodium iodide symporter proteins and uses thereof | 
| 10/07/2014 | US8852550 Chelator conjugates | 
| 10/07/2014 | US8851893 Interactive dental restorative network | 
| 10/02/2014 | WO2014160627A1 Anti-cd276 polypeptides, proteins, and chimeric antigen receptors | 
| 10/02/2014 | WO2014160507A1 Fusion proteins comprising pdgf and vegf binding portions and methods of using thereof | 
| 10/02/2014 | WO2014160463A1 Prefusion rsv f proteins and their use | 
| 10/02/2014 | WO2014160441A1 Neuroactive steroids, compositions, and uses thereof | 
| 10/02/2014 | WO2014160438A1 Fragments of p97 and uses thereof | 
| 10/02/2014 | WO2014160305A1 Ligand-therapeutic agent conjugates and silicon-based linkers | 
| 10/02/2014 | WO2014160272A1 Targeted elimination of factor viii immune cells | 
| 10/02/2014 | WO2014160122A1 Maize stress related transcription factor 18 and uses thereof | 
| 10/02/2014 | WO2014159947A1 High affinity digoxigenin binding proteins | 
| 10/02/2014 | WO2014159941A1 Amyloidosis-inhibiting polypeptides and their use | 
| 10/02/2014 | WO2014159917A2 Treatment for exposure to nerve agent | 
| 10/02/2014 | WO2014159863A1 Thermo-sensitive bone growth compositions | 
| 10/02/2014 | WO2014159725A1 Proteins specific for baff and b7rp1 and uses thereof | 
| 10/02/2014 | WO2014159714A1 Hepatitis b virus vaccines | 
| 10/02/2014 | WO2014159707A1 An ex vivo human multiple myeloma cancer niche and its use as a model for multiple myeloma | 
| 10/02/2014 | WO2014159550A1 Diffocins and methods of use thereof | 
| 10/02/2014 | WO2014159441A1 Removal of leaked affinity purification ligand | 
| 10/02/2014 | WO2014159242A1 Notch 3 mutants and uses thereof | 
| 10/02/2014 | WO2014159064A1 Methods of increasing protein purity using protein a based chromatography | 
| 10/02/2014 | WO2014158089A1 Method for cell culture | 
| 10/02/2014 | WO2014157820A1 Novel gene for bacillus thuringiensis endotoxin protein having enhanced insecticidal activity against lepidopteran pests, and method for producing same | 
| 10/02/2014 | WO2014157704A1 Conjugate vaccine using trimming function of erap1 | 
| 10/02/2014 | WO2014157692A1 Wt1-antigen peptide conjugate vaccine |